Skip to main content
Home
PRODUCTS
Disease areas
Evidences
SEPSIS
COVID19
ALLERGY
FERRITIN
cSOFA
SCIENTIFIC PUBLICATIONS
About Us
News
Contact
Career
Menu
Select your language
en
fr
de
it
Go
Toggle navigation
Mobile menu
Home
Products
Disease areas
Evidences
SEPSIS
COVID19
ALLERGY
FERRITIN
cSOFA
SCIENTIFIC PUBLICATIONS
About Us
Contact
News
Career
News
Media & press
All
Articles
News
Press Releases
Apply
Articles
Friday, 28 May 2021
New data confirms the clinical benefit of PSP for the diagnosis of severe infections in hospitalized adults
Read article
Articles
Tuesday, 20 April 2021
The Pancreatic Stone Protein (PSP) biomarker rises earlier than C-Reactive protein (CRP) and procalcitonin (PCT) in sepsis, a new study shows.
Read article
Articles
Thursday, 08 April 2021
Great symposium on the PSP Sepsis Biomarker - hosted by Abionic and Palex at the All-Virtual Galisepsis Congress
Read article
Press Releases
Monday, 30 November 2020
Abionic launches first Covid-19 severity test to triage patients quickly and accurately
Read article
Articles
Wednesday, 18 November 2020
Web Symposium hosted by Abionic - Early Identification of Sepsis
Read article
News
Wednesday, 20 May 2020
COVID-19 : LA SOLUTION DE LA SCALE-UP ABIONIC
Read article
News
Wednesday, 01 April 2020
The Battle for a Better Sepsis Test
Read article
News
Thursday, 19 March 2020
Septic shock is one of the major complications of Covid-19. Vaud-based start-up Abionic, specialized in the miniaturization of diagnostic tests, has developed a test that can detect sepsis in five minutes.
Read article
News
Wednesday, 11 March 2020
Basé au Biopôle à Lausanne, la start-up Abionic a développé un test qui permet de diagnostiquer un sepsis (choc septique) en cinq minutes à partir d’une goutte de sang. Sa détection précoce devrait permettre d’aider à prévenir ce syndrome, responsable d’environ 400 décès par an en Suisse romande.
Read article
News
Thursday, 16 January 2020
Les tests de diagnostic ultra-rapide d’Abionic bientôt dans les hôpitaux d'Europe et des Etats-Unis
Read article
Press Releases
Thursday, 09 January 2020
Abionic integrates first patients in US clinical trial for sepsis diagnosis method
Read article
Press Releases
Friday, 13 September 2019
Abionic: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care
Read article
News
Thursday, 05 September 2019
Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests
Read article
News
Thursday, 05 September 2019
Abionic unterzeichnet Vereinbarung zur Optimierung des Asthma-Managements in den USA durch innovative schnelle Point-of-Care-Tests
Read article
News
Thursday, 05 September 2019
Abionic dispose désormais d’une référence précieuse avec Genentech
Read article
News
Thursday, 05 September 2019
Abionic teams up with Genentech to develop rapid Asthma test
Read article
Press Releases
Thursday, 05 September 2019
Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests
Read article
News
Thursday, 05 September 2019
Tracking the growth of Switzerland’s best scale-ups
Read article
News
Monday, 29 July 2019
“In five years there will be five tech hubs in Europe that matter, and Lausanne will be one of them”
Read article
News
Tuesday, 25 June 2019
How to increase the number of MedTech unicorns in Europe?
Read article
Load More